When the U.S. Food & Drug Administration (FDA) announced its approval of the generic version of mifepristone in October, the pro-life movement immediately acted. AAPLOG joined a coalition of pro-life advocates in a letter spearheaded by Live Action’s Lila Rose to Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Martin Makary urging them to reverse the erroneous decision and to consider taking mifepristone off the market entirely.
The letter expresses “grave concern” and points out contradictions between the decision and Secretary Kennedy’s recent statements on September 4, 2025, when he claimed the Biden Administration “twisted the data to bury one of the safety signals…around 11 percent,” promising to “make sure it doesn’t happen anymore.”
AAPLOG has long voiced our concerns about mifepristone and has been urging the Trump administration to ensure the FDA is doing its job of protecting American women, girls and children from harmful drugs like mifepristone. Mifepristone induced abortions make up at least 63% of abortions in the United States. Since there’s no national abortion reporting law and a lack of regulations for abortion pills, this number could very well be significantly higher than reported. Now, virtually anyone can access these pills, giving abusers the upper hand with women, girls, and preborn children on the losing end.
The proliferation of these drugs comes with increased deaths of our preborn patients and severe injuries to women, as seen in a recent groundbreaking report from the Ethics and Public Policy Center (EPPC) entitled “The Abortion Pill Harms Women.”
The EPPC looked at data from 865,727 chemical abortions from 2017 to 2023 and found that “Serious adverse events from mifepristone are approximately 22 times more frequent. Nearly 11 percent of women experience ‘sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion.’”
We support evidence-based life-affirming medical care and the removal of mifepristone from the market for induced abortion, and we stand by the letter stating that “every abortion is a violation of human rights”—and a violation of our oath to both patients: the mother and her preborn child.
